Ablative Therapies for Breast Cancer: State of Art.

Autor: Carriero S; Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy., Lanza C; Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy., Pellegrino G; Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy., Ascenti V; Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy., Sattin C; Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy., Pizzi C; Postgraduate School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy., Angileri SA; Department of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy., Biondetti P; Department of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy.; 9304Università Degli Studi di Milano, Milan, Italy., Ianniello AA; Department of Diagnostic and Interventional Radiology, Ospedale Luigi Sacco, Milan, Italy., Piacentino F; Department of Diagnostic and Interventional Radiology, Ospedale di Circolo, Varese, Italy., Lavorato R; Researcher at Diagnostic and Interventional Radiology Department, 9339IRCCS Ca' Granda Fondazione Ospedale Maggiore Policlinico, Milan, Italy., Ierardi AM; Department of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy., Carrafiello G; Department of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Policlinico di Milano Ospedale Maggiore, Via Sforza 35, 20122 Milan, Italy.; 9304Università Degli Studi di Milano, Milan, Italy.
Jazyk: angličtina
Zdroj: Technology in cancer research & treatment [Technol Cancer Res Treat] 2023 Jan-Dec; Vol. 22, pp. 15330338231157193.
DOI: 10.1177/15330338231157193
Abstrakt: Breast cancer (BC) is the most frequently diagnosed malignancy among women. In the past two decades, new technologies and BC screening have led to the diagnosis of smaller and earlier-stage BC (ESBC). Therefore, percutaneous minimally invasive techniques (PMIT) were adopted to treat patients unfit for surgery, women who refuse it, or elderly patients with comorbidities that could make surgery a difficult and life-threatening treatment. The target of PMIT is small-size ESBC with the scope of obtaining similar efficacy as surgery. Minimally invasive treatments are convenient alternatives with promising effectiveness, lower morbidity, less cost, less scarring and pain, and more satisfying cosmetic results. Ablative techniques used in BC are cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound (US), and laser ablation. The aim of our study is to discuss the current status of percutaneous management of BC, evaluate the clinical outcomes of PMIT in BC, and analyze future perspectives regarding ablation therapy in BC.
Databáze: MEDLINE